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Periprosthetic Knee Infection: Ten Strategies That Work
Javad Parvizi, MD, Priscilla Ku Cavanaugh, MS, and Claudio Diaz-Ledezma, MD
Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA

Periprosthetic joint infection (PJI) is one of the most serious complications following total knee arthroplasty (TKA). The demand for TKA is
rapidly increasing, resulting in a subsequent increase in infections involving knee prosthesis. Despite the existence of common management
practices, the best approach for several aspects in the management of periprosthetic knee infection remains controversial. This review examines
the current understanding in the management of the following aspects of PJI: preoperative risk stratification, preoperative antibiotics, preoperative
skin preparation, outpatient diagnosis, assessing for infection in revision cases, improving culture utility, irrigation and debridement, one and twostage revision, and patient prognostic information. Moreover, ten strategies for the management of periprosthetic knee infection based on available
literature, and experience of the authors were reviewed.
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Introduction
It is well recognized that a periprosthetic joint infection (PJI)
after knee arthroplasty is a catastrophic complication not only for
the patient, but also for the health-care system. During the last
decade, clinical research has considerably improved our comprehension of this topic. However, we are still in the process of producing high-level evidence to support our daily clinical practice.
In this article we will review ten strategies that work in managing
knee PJI.
1. Preoperative Risk Stratification
From our standpoint, the first step to succeed in the battle
against knee PJI is prevention. Consequently, in order to stratify
the patient’s risk, knowledge of risk factors in the development
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of PJI should be mandatory for each surgeon that is involved in
knee arthroplasty. Optimization of modifiable variables that may
influence this risk is also critical. A recent study by Namba et al.1)
evaluated 56,216 total knee arthroplasty (TKA) surgeries. The
study found an incidence of deep infection of 0.72% (404/56,216).
The risk factors for infection were body mass index (BMI) of
≥35 (hazard ratio [HR], 1.47), diabetes mellitus (HR, 1.28), male
sex (HR, 1.89), an American Society of Anesthesiologists (ASA)
score of ≥3 (HR, 1.65), osteonecrosis (HR, 3.65), and posttraumatic arthritis (HR, 3.23). Hispanic race was a protective factor
(HR, 0.69), the use of antibiotic irrigation (HR, 0.67), a bilateral
procedure (HR, 0.51), and a lower annual hospital volume (HR,
0.33). Surgical risk factors included quadriceps-release exposure
(HR, 4.76), and the use of antibiotic-laden cement (HR, 1.53).
Operative time was a risk factor, with a 9% increased risk per
fifteen-minute increments. Although some risk factors found in
this study are debatable, the study highlights some of the important predisposing factors for infection.
Obesity and diabetes are both well-known risk factors for knee
PJI. According to the American Association of Hip and Knee
Surgeons (AAHKS), prior to surgery, a patient with a BMI over
40 should be counseled regarding weight loss2). In addition,
AAHKS has emphasized the importance of a nutritional evaluation prior to surgery2). Regarding diabetes, a large Finnish study
corroborated its relevance as a strong risk factor for infections3).
Although Hemoglobin A1C has been used to evaluate arthrowww.jksrr.org
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plasty patients, a recent publication from Iorio et al.4) showed
that it is probably a suboptimal preoperative measurement due
to its inability to prognosticate complications. We believe that an
exhaustive preoperative evaluation, and glycemic level optimization is an indispensable component of the preoperative work up,
and must be conducted by a general internist, or medicine subspecialist. Currently, the evidence is not able to present a definite
threshold regarding BMI and glycemic control in order to establish a clear preoperative recommendation for knee arthroplasty
patients.
Another attractive strategy is to calculate a preoperative risk of
PJI using a scoring system. The Mayo Clinic recently presented a
prosthetic joint infection risk score, which demonstrated a good
capacity to discriminate subjects who will develop a PJI from
those who will not (C-index of 0.722)5). It includes the BMI, presence of prior operations on the index joint, prior arthroplasty,
immunosuppression, ASA score, and procedure duration5). After
adding postoperative wound drainage to the previous variables,
the 1-month post surgery risk score presents a C- index of 0.716.
A recent study conducted in Korea described a prevalence of
surgical site infections (SSI) in 161 of 6,848 cases (2.35%)6). Interestingly, the authors suggested that the risk factors for SSI differ
between total hip arthroplasty (THA), and TKA. Independent
risk factors for SSI in TKA were male gender, and an operating
room without laminar flow. More than 10 procedures per month
was a protective factor for knee PJI6).
A recent systematic review and meta-analysis indicate that,
compared with osteoarthritis (OA) patients, patients with rheumatoid arthritis have a higher risk of infection following TKA7).
Another important risk factor is revision surgical procedures8).
A study from our institution revealed that the risk of infection
among patients undergoing revisions was 10-fold higher (9%)8)
than for patients undergoing primary TKA (0.5%−1%)9). The risk
was predicted by factors such as revision due to infection, higher
Charlson comorbidity index, and diagnosis other than OA at the
time of the primary procedure.
Understanding the risk factors for PJI, allows implementation
of strategies that aims to reverse some of these potential risk factors and reduce the burden of infection.
2. Preoperative Antibiotics
One of the most effective strategies for the prevention of infection in modern orthopaedic literature is the administration of
preoperative antibiotics10,11). In order to achieve optimal results,
adequate concentration of antibiotics should be present during
the entire time the incision is open, when the greatest risk for

contamination is present10). For predictable and rapid delivery
of antibiotics, systematic intravenous (IV) administration is the
method of choice12).
Conflicting opinions exist as to what the optimal time window
for prophylaxis administration should be12). Some studies have
shown that the best time for administration is within 30 minutes
of incision13), while others support administration within 30−59
minutes14). Based on The American Academy of Orthopaedic
Surgeons (AAOS) and The Centers for Disease Control (CDC)
guidelines, prophylactic antibiotics should be administered
within one hour before the surgical incision15). When a proximal
tourniquet is used, administration of the entire dose of antibiotic
should occur before inflation of the tourniquet12,15). Duration of
antibiotic coverage should not exceed 24 hours postoperatively15),
doing so may increase the risk for adverse effects of antibiotics
without proven benefits15,16). Avoiding unnecessary antibiotic use
will also minimize the risk ofbacterial resistance17). Furthermore,
intraoperative dose of antibiotic should be repeated if there is
significant blood loss, or if operative time exceeds two times the
half-life of antibiotic15,18).
Currently, the most widely used prophylactic antibiotics for
prevention of PJI are first and second generation cephalosporins
because of their excellent tissue penetration, bioavailability, and
coverage against common organisms such as Staphylococcus species, and enteric pathogens12). In patients undergoing orthopaedic
procedures, cefuroxamine and cefazolin are the preferred antibiotics14). These antibiotics may not be appropriate in certain cases,
and the addition of vancomycin may be warranted12,15). AAOS
guidelines recommend vancomycin in facilities with methicillinresistant staphylococcus aureus (MRSA) outbreaks, and in patients with known MRSA colonization15). Additionally, vancomycin should be considered in institutionalized patients (dialysisdependent patients and nursing home residents), and health care
workers12). Patients with a documented anaphylactic reaction
to penicillin can either receive clindamycin or vancomycin12,15),
however, our institution prefers vancomycin to avoid the potential for clindamycin-associated clostridium difficile enteritis12).
3. Skin Preparation
Preoperative skin preparation is of common practice in the orthopaedic community. Skin preparation prior to surgery includes
skin decolonization, antisepsis, hand washing by the surgeon,
and hair removal. Ample evidence exists in support of the role of
preoperative cleansing in reduction of skin bacteria load19,20), but
how this translates to prevention of SSI is unclear.
Preoperative showering or cleansing with an antiseptic agent at
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least the night before a surgical procedure has been recommended by the CDC21). In two prospective consecutive series, patients
who used chlorhexidine gluconate (CHG) impregnated wipes the
night before, and the morning of the surgery had a lower incidence of SSI as compared with those who did not comply to the
protocol in both THA and TKA procedures. In contrast, a Cochrane review of 7 randomized trials concluded that preoperative
showering with CHG did not reduce the rate of SSI as compared
to a no shower group or placebo group22). Despite conflicting
data regarding preoperative showers reducing SSI incidence, the
simplicity and cost-effectiveness of this method justifies its current recommendation23).
Regarding skin preoperative disinfection, the discussion has focused on the selection of an optimal antiseptic agent12). The main
types of antiseptic agents are: alcohol based solutions, povidoneiodine and CHG24,25). In studies comparing CHG and povidoneiodine the results are conflicting. Darouiche et al.26) demonstrated
that CHG in alcohol was superior in reducing the rate of SSI as
compared to aqueous povidone-iodine. However, the iodine
preparation in the study did not use an alcohol solvent, hence
allowing for the possibility that alcohol may play a role. In fact,
in a study involving general surgery patients, povidone-iodine
prepped patients had a lower rate of SSI when alcohol was used
(either as a solvent or scrub)27). Overall, the literature suggests
some value in the combination of alcohol with antiseptic agents,
and that CHG combined with alcohol may be superior to other
combinations26,28,29).
In regards to preoperative hair removal, the CDC recommends
that it should be done immediately before the procedure, and
electric clippers are preferred over razor blades12,21). Tanner et
al.30) conducted a meta-analysis that showed that electric clippers
were associated with fewer SSIs than with razor shaving.
Hand washing by the surgeon and medical personnel is a difficult topic to evaluate due to the variability in the literature regarding duration, and optimal antiseptic agent. One study examining
surgical scrub time, and subsequent bacterial growth found no
significant difference between a 2 or a 3 minute scrub31). Currently, The Association of Perioperative Registered Nurses states
that a 3−4 minute scrub is as effective as a 5 minute scrub, while
the CDC recommends 2−5 minutes21). Data on hand rub (alcohol
based) and hand scrub agents suggest no significant difference
in efficacy between the two32). A trial of 4,387 patients who underwent clean, and clean contaminated surgery using either traditional hand scrubbing techniques or waterless, alcohol-based
antiseptics showed no difference in SSI rates33). Based on current
literature, medical personnel should consider a minimum dura-
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tion of 2−3 minutes for surgical hand antisepsis using either hand
rub or hand scrub solution31-33).
4. Diagnosis of Periprosthetic Joint Infection
The diagnosis of PJI should be suspected in all patients evaluated for a painful TKA. The AAOS established diagnostic guidelines that help identify PJI of the knee34). The measurement of
serum markers such as C-reactive protein (CRP), and the erythrocyte sedimentation rate (ESR) is highly valuable in reaching a
diagnosis of PJI. It must be noted that these tests are not diagnostic independently. According to the AAOS34) and the Infectious
Diseases Society of America guidelines35), if serum markers are
elevated, a joint aspiration should be performed. Our institution
always includes cytochemical fluid analysis, and two cultures
after every knee aspiration. More recently, we have added the
evaluation of the leukocyte esterase test also36).
We encourage the surgeons to be cognizant of the Musculoskeletal Infection Society (MSIS) PJI diagnostic criteria, that aim to
provide a standard definition of PJI37). The criteria can be used as
a guide to establish a diagnosis when PJI is suspected. Taking into
consideration the benefits, costs and risks of different strategies of
PJI diagnosis, the use of serum markers followed by knee arthrocentesis is a highly efficient strategy.
A recent study from our group determined the thresholds for
serum markers to diagnose PJI using the MSIS criteria. In early
postoperative knee PJI, the ESR threshold was 54 mm/hour, and
CRP was 23.5 mg/L. In late-chronic knee PJI the thresholds were
46.5 mm/hour for ESR, and 23.5 mg/L for CRP38). A study from
another group established that the rate of false negatives was 9.2%
for ESR, 5.3% for CRP, and 11% for combined ESR and CRP
when diagnosing knee PJI. The authors believe that one of the
factors that may explain these observations is that some patients
may not mount a sufficient immune response, especially in early
postoperative infections39). For this reason, a joint aspiration
should be conducted even if serum markers are normal in those
cases with high clinical suspicion, or known risk factors for knee
PJI.
Our group also presented the value of studying the CRP in the
synovial fluid, which may be an additional tool to improve our
diagnostic alternatives40).
5. Intraoperative Assessment in Every Revision Case
From our standpoint and according to the recommendations
made by the AAOS, surgeons should always perform a PJI diagnostic workup in every revision case. This process should start
when the decision to undergo a revision is made, and the strate-

158 Parvizi et al. Periprosthetic Knee Infection
gies described above are used. Once the patient is in the operation room, three main strategies can be employed: 1) cultures, 2)
frozen sections, and 3) implant-related studies.
Concerning intraoperative cultures, one of the most important
steps is to not withhold the preoperative antibiotics in revision
cases. A multicenter randomized study, demonstrated that intraoperative cultures yielded the same organisms as preoperative cultures in 28 of 34 patients (82%) randomized to receive
antibiotics before the skin incision compared to 25 of 31 patients
(81%) randomized to receive antibiotics after obtaining operative cultures41). In regards to the type of cultures that should be
obtained during the surgery, a study conducted in our institution
demonstrated that tissue cultures are better than swab cultures.
Tissue cultures demonstrated higher sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV)
for diagnosing PJI than swab cultures. Swab cultures had more
false-negative and false-positive results than tissue cultures42) Another important strategy is to obtain the synovial fluid culture in
blood culture flasks, due to its higher sensitivity, specificity, and
both PPV and NPV for diagnosis of PJI when compared with
standard tissue and swab samples43).
Regarding the use of frozen sections, it must be noted that they
represent one of the diagnostic criteria in the MSIS definition.
A recent systematic review and meta-analysis by Tsaras et al.44)
showed that intraoperative frozen sections are helpful in the diagnosis of culture-positive PJI, but had moderate accuracy in ruling out this diagnosis. According to the authors, frozen section is
especially valuable if the suspicion of infection remains high even
after a negative preoperative evaluation. The optimum diagnostic
threshold (number of polymorphonuclear leukocyte per highpower field) could not be discerned in this study.
Implant sonication is proving to be an interesting technology45).
Its role has not been completely determined in the diagnostic
work-up of PJI, especially considering the costs associated.
6. How to Improve the Utility of Cultures?
Cultures of tissue and synovial fluid obtained from an affected
joint play a major role in both the diagnosis and treatment of
PJI12). These cultures are used to confirm, and not to screen for
PJI12). Currently, diagnosis of PJI can be made from two separate
fluid or tissue samples from an affected joint37). Not only do cultures confirm a PJI diagnosis, they also allow for sensitivity-guided treatment. However, in 7% to 12% of PJI cases cultures may be
negative even when clear signs of infection are present46,47).
Negative cultures may be caused by a variety of reasons, including inappropriate collection of sample, use of antimicrobial

therapy prior to collection, short incubation duration, and possible fungal or mycobacterial infection12). In the setting of a true
PJI, negative cultures limit the ability to tailor antibiotic treatment
and may hinder justification for revision surgery12). Thus, attention should be directed at decreasing the incidence of negative
cultures.
Strategy for obtaining positive cultures includes withholding
aspiration of joints for at least two weeks prior to sample collection, followed by a prolonged period of incubation12,46). A study
by Schaefer et al.48) described that prolonged incubation for at
least 14 days increased the identification of organisms that would
otherwise remain culture negative. Certain pathogens that are
difficult to isolate using traditional cultures include fungi, mycobacteria, and organisms encapsulated in biofilm46). Proper media
should be used in cases where fungi or mycobacteria are suspected12). A repeat aspiration should be considered in the event of
inconclusive preoperative aspiration, negative cultures, elevated
inflammatory markers, and high PJI suspicion12).
7. Irrigation and Debridement: When and How?
The use of irrigation and debridement (I&D) with or without
modular exchange as an appropriate alternative for treatment of
PJI remains controversial. This less invasive procedure is commonly used despite its rate of success ranging between 0% and
89%49). I&D provides the option for a less complex surgery, and
lower cost when compared to two-staged procedures50). The potential advantages of I&D over two-stage exchange justify its continued practice and further investigation of factors that predict its
optimal use.
I&D has been considered a viable option for early postoperative
or late hematogenous infections51). Previous studies have suggested that the ability of I&D to control infection may be related to its
timing relative to index total joint arthroplasty, and duration of
symptoms52-54). Hartman et al.52) found significant improvement
in I&D success rates if used within 4 weeks of index knee surgery.
In addition to short duration of symptoms, the literature suggests
a higher I&D success rate in healthier patients, and in infections
with low virulent organisms55-58). Azzam et al.59) described that
patients with a higher ASA score, had higher failure rates. Furthermore, several studies recognize Staphylococcal infections as a
risk factor for failure in I&D60). Thus, I&D should be considered
in immunologically optimized patients with acute onset of symptoms infected with low virulent organisms.
Once the decision to perform an I&D procedure is made, preoperative optimization of the patient should be attempted before
proceeding12). In the operating room, aggressive debridement
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of all foreign and affected periarticular tissue should be performed12). At our institution, retained components are scrubbed
with Dakin’s solution and using a new, clean instrument for each
collection, at least 3 tissue samples are then obtained12). Thorough
irrigation using low pressure pulse lavage or bulb irrigation of
the joint with up to 9 liters of solution is performed12,61,62). Finally,
gloves, gowns and surgical setup should be changed between the
I&D procedure, and the modular component exchange12).
8. Revision in One Stage: When and How?
One-stage exchange arthroplasty for PJI has become the subject
of interest due to potential advantages over two-stage exchange.
Main advantages that proponents focus on are the need for a
single operation, decreased morbidity, lower cost, and improved
functional results63-65). Regarding efficacy of the procedure, several retrospective studies have reported rates of infection control
between 73% and 93%66-69).
Although advantages may exist in one-stage exchange, studies
emphasize that success of the procedure depends on both patient, and infection related factors12). Jackson and Schmalzried70)
performed a literature review to determine when single-stage
exchange is most successful in the setting of an infected hip. Variables associated with successful outcomes included the absence of
wound complications after index THA, healthy patients, presence
of methicillin-sensitive organisms, and organism susceptibility
to antibiotic-laden bone cement70). Factors that predicted failure
included polymicrobial infection, presence of gram negative organisms, and methicillin-resistant organisms70). Furthermore, the
following may be considered contraindications: systemic infection, severe soft tissue involvement, inability to identify a microorganism preoperatively, and presence of a sinus tract10,12,35,70-72).
Identifying ways to optimize results of one-stage exchange helps
determine appropriate indications. At our institution, indications
for one-stage exchange include: a healthy host, acute postoperative infection, susceptible organism, and adequate soft tissue coverage12).
In one-stage exchange arthroplasty, a patient undergoes a radical synovectomy, debridement of infected tissue and removal of
foreign material (including prosthesis and cement)65). Multiple
cultures should be taken for final culture analysis12). Prior to
the reimplantation of the prosthesis, the patient should be reprepped, and a change of gloves and surgical instruments should
occur65). After implantation of the antibiotic impregnated cement, the wound is irrigated with dilute betadine solution before
final closure65). Systemic antibiotics are usually given for a total of
6 weeks, beginning with 2 weeks of IV antibiotics followed by 4
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weeks of oral antibiotics65).
9. Revision in Two Stages: When and How?
The two-stage exchange arthroplasty is currently the most accepted procedure for the treatment of PJI in North America73-75).
Two-stage exchange involves resection of the implants, meticulous debridement and irrigation, placement of a temporary
antibiotic-impregnated cement spacer, and delayed component
reimplantation12,65). Although the main role of two-stage revision
has been in chronic PJI management, it is increasingly considered
in cases of acute PJI where initial I&D or one-stage exchange procedures have failed12,76). Literature on two-stage exchange reports
variable success rates, and sufficient data directly comparing it to
one-stage revision is lacking. However, a recent systematic review
demonstrated an average success rate of 90% after two-stage exchange for knee prosthesis infection75). The study also reported
that two-stage exchange provided better outcomes than one-stage
revision for septic knee prosthesis75).
Currently, there is insufficient data to provide clear indications
for two-stage exchange35,70,72). Infections with resistant organisms
have been associated with higher failure rates in the treatment of
PJI77,78). Some studies suggest that two-stage exchange may be the
preferred treatment for highly virulent organisms79,80). Parvizi et
al.79) examined surgical treatment success of knee and hip MRSA
infections, and reported infection control by I&D and two-stage
exchange as 37% and 75% respectively, suggesting superior outcomes with the latter. Furthermore, Oussedik et al.64) reported
significant bone loss, and soft-tissue compromise as factors in favor of a two-stage exchange over a one-stage revision. Insufficient
soft-tissue coverage may be an indication for two-stage exchange,
especially if time is required for flap development. Currently at
our institution, common indications for this procedure are as follows: chronic PJI, failed I&D, and acute infections associated with
an immunocompromised host or virulent organism12).
Two-stage exchange begins with thorough removal of infected
tissue and foreign material, followed by irrigation12). The first
stage involves insertion of either a static or dynamic antibioticimpregnated spacer12), most commonly using vancomycin, tobramycin, and gentamicin as the antibiotic12,81). Postoperatively,
the patient receives a course of antibiotic treatment, usually for
6 weeks82), followed by reimplantation of a new prosthesis when
the clinician deems the infection resolved12,83-85). A combination
of clinical judgment, aspiration, and serological data can aid the
clinician’s decision on appropriate time for reimplantation12,82).
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10. Patient Information about Their Prognosis
A patient diagnosed with a knee PJI should be informed about
the prognosis. Providing information is key in maintaining realistic expectations, and avoiding medicolegal issues. Ideally, the
patient’s family should also be involved during the presentation
of prognostic information.
Although the term “successful treatment” in PJI has been widely
used, until recently, its definition was non-uniform. Our group
found more than 10 different definitions of success in the current
literature86), thus, we decided to create a Delphi-based consensus
definition. The study was published recently86), and it described
success as 1) infection eradication (characterized by a healed
wound without fistula, drainage, or pain), and no infection recurrence caused by the same organism strain, 2) no subsequent
surgical intervention for infection after reimplantation surgery;
and, 3) no occurrence of PJI-related mortality (by causes such as
sepsis, necrotizing fasciitis). We expect that in the near future this
definition will help us better present prognostic information, and
the overall probability to succeed to optimize patient understanding.
In terms of infection eradication, according to a meta-analysis
by Jamsen et al.87), the failure to eradicate infection after treatment
of a periprosthetic knee infection ranged from 0%−31%. Recurrent infections occurred in 0%−18%, and new infections varied
from 0%−31%87). Regarding functional outcomes, Barrack et
al.88), in a multicenter study of surgical outcomes following revision knee arthroplasty, patients demonstrated a lower Knee Society Score (KSS) in their cohort of septic revisions compared with
revisions for aseptic failure. Concerning the radical management
of failed TKA infection treatment, Chen et al.89) demonstrated
that patients with knee fusions had better functional scores than
knee amputations.
In TKA revisions, Barrack et al.88) demonstrated that revisions
due to infection had no differences regarding patients’ satisfaction compared with aseptic revision cases. This fact has been supported in a subsequent study by Patil et al.90).

and consequences of periprosthetic knee infection.
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